Federated Hermes’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4K | Sell |
3,442
-579,287
| -99% | -$2.09M | ﹤0.01% | 1788 |
|
|
2025
Q1 | $1.74M | Sell |
582,729
-210
| -0% | -$628 | ﹤0.01% | 972 |
|
|
2024
Q4 | $1.95M | Buy |
582,939
+10,856
| +2% | +$36.4K | ﹤0.01% | 940 |
|
|
2024
Q3 | $1.92M | Buy |
572,083
+815
| +0.1% | +$2.73K | ﹤0.01% | 944 |
|
|
2024
Q2 | $1.89M | Sell |
571,268
-91
| -0% | -$301 | ﹤0.01% | 936 |
|
|
2024
Q1 | $2.31M | Sell |
571,359
-24,333
| -4% | -$98.3K | 0.01% | 896 |
|
|
2023
Q4 | $1.82M | Sell |
595,692
-13,094
| -2% | -$39.9K | ﹤0.01% | 975 |
|
|
2023
Q3 | $1.83M | Sell |
608,786
-5,204
| -0.8% | -$15.6K | ﹤0.01% | 951 |
|
|
2023
Q2 | $2.3M | Sell |
613,990
-1,425,066
| -70% | -$5.33M | 0.01% | 908 |
|
|
2023
Q1 | $6.83M | Sell |
2,039,056
-1,041,841
| -34% | -$3.49M | 0.02% | 633 |
|
|
2022
Q4 | $14.8M | Sell |
3,080,897
-545,921
| -15% | -$2.63M | 0.04% | 447 |
|
|
2022
Q3 | $20.6M | Buy |
3,626,818
+38,687
| +1% | +$220K | 0.06% | 374 |
|
|
2022
Q2 | $25.5M | Buy |
3,588,131
+1,536,799
| +75% | +$10.9M | 0.07% | 332 |
|
|
2022
Q1 | $14.8M | Buy |
+2,051,332
| New | +$14.8M | 0.03% | 514 |
|